Compare ANL & ABR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ANL | ABR |
|---|---|---|
| Founded | 2004 | 2003 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | | Real Estate Investment Trusts |
| Sector | | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 998.8M | 809.7M |
| IPO Year | 2022 | 2003 |
| Metric | ANL | ABR |
|---|---|---|
| Price | $15.11 | $3.43 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 5 |
| Target Price | ★ $29.50 | $5.17 |
| AVG Volume (30 Days) | 143.5K | ★ 4.8M |
| Earning Date | 08-14-2026 | 10-30-2026 |
| Dividend Yield | N/A | ★ 19.10% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $243.83 | N/A |
| Revenue Next Year | N/A | $3.27 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.88 | $3.63 |
| 52 Week High | $17.25 | $12.36 |
| Indicator | ANL | ABR |
|---|---|---|
| Relative Strength Index (RSI) | 50.08 | 15.79 |
| Support Level | $14.70 | N/A |
| Resistance Level | $15.29 | $5.41 |
| Average True Range (ATR) | 1.02 | 0.17 |
| MACD | -0.11 | -0.08 |
| Stochastic Oscillator | 29.50 | 2.00 |
Adlai Nortye Ltd is a clinical-stage company at the forefront of discovering and developing cancer therapies. The company is building a robust pipeline of drug candidates focused on two key areas where it believes it can make a difference RAS-targeting therapies: its is tackling RAS-driven cancers with AN9025, an oral pan-RAS(ON) inhibitor, and AN4035, a CEACAM5-targeting ADC delivering a potent pan-RAS(ON) inhibitor directly to tumors; Next-generation cancer immunotherapies: its candidates, AN8025 (a tri-functional fusion protein of alphaPD-L1 x CD86 variant x LAG3 variant), a T-cell and antigen-presenting cell modulator, and AN4005 (a first-in-class oral small-molecule PD-L1 inhibitor), are designed to activate cancer immunity in novel ways.
Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily, SFR, and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment.